Robust osteogenic efficacy of 2α-heteroarylalkyl vitamin D analogue AH-1 in VDR (R270L) hereditary vitamin D-dependent rickets model rats.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 07 2022
Historique:
received: 11 04 2022
accepted: 15 07 2022
entrez: 22 7 2022
pubmed: 23 7 2022
medline: 27 7 2022
Statut: epublish

Résumé

Active vitamin D form 1α,25-dihydroxtvitamin D

Identifiants

pubmed: 35869242
doi: 10.1038/s41598-022-16819-7
pii: 10.1038/s41598-022-16819-7
pmc: PMC9307643
doi:

Substances chimiques

Ligands 0
Receptors, Calcitriol 0
VDR protein, human 0
Vitamin D 1406-16-2
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12517

Informations de copyright

© 2022. The Author(s).

Références

J Biol Chem. 2001 Aug 3;276(31):29148-56
pubmed: 11369766
Int J Biol Macromol. 2022 Jun 1;209(Pt A):1111-1123
pubmed: 35421413
Mol Endocrinol. 2005 Apr;19(4):855-62
pubmed: 15591533
J Clin Endocrinol Metab. 2005 Sep;90(9):5031-6
pubmed: 15972580
Breast Cancer Res Treat. 2009 Jan;113(1):31-41
pubmed: 18205042
Endocrinol Metab Clin North Am. 2010 Jun;39(2):333-46, table of contents
pubmed: 20511055
FASEB J. 2004 Feb;18(2):332-4
pubmed: 14657005
Sci Rep. 2021 Apr 13;11(1):8002
pubmed: 33850196
Calcif Tissue Int. 2013 Feb;92(2):77-98
pubmed: 22782502
J Clin Invest. 1993 Jul;92(1):12-6
pubmed: 8392085
Endocr J. 2001 Aug;48(4):427-32
pubmed: 11603564
J Steroid Biochem Mol Biol. 1996 Jan;56(1-6 Spec No):13-22
pubmed: 8603033
Chem Pharm Bull (Tokyo). 2003 Mar;51(3):357-8
pubmed: 12612432
Eur J Biochem. 2000 Oct;267(20):6158-65
pubmed: 11012668
Mol Cell. 2000 Jan;5(1):173-9
pubmed: 10678179
J Steroid Biochem Mol Biol. 2019 Jan;185:71-79
pubmed: 30031146
J Comput Chem. 2003 Oct;24(13):1549-62
pubmed: 12925999
J Org Chem. 2004 Oct 29;69(22):7463-71
pubmed: 15497970
ACS Med Chem Lett. 2013 May 28;4(7):671-4
pubmed: 24900728
Mol Cell Endocrinol. 2014 Feb 15;382(2):960-70
pubmed: 24291609
J Steroid Biochem Mol Biol. 2010 Feb 15;118(3):162-70
pubmed: 19944755
Bioorg Med Chem. 2009 Jul 1;17(13):4296-301
pubmed: 19482479
J Steroid Biochem Mol Biol. 2018 Apr;178:55-59
pubmed: 29101064
Oncotarget. 2016 Jan 5;7(1):995-1013
pubmed: 26654942
Horm Res. 2002;57(3-4):73-8
pubmed: 12006701
Cell Chem Biol. 2017 Feb 16;24(2):207-217
pubmed: 28132894
Front Biosci. 2005 Jan 01;10:119-34
pubmed: 15574355
FASEB J. 2014 Jul;28(7):2775-89
pubmed: 24668754
Vitam Horm. 2016;100:379-94
pubmed: 26827960
J Steroid Biochem Mol Biol. 2017 Oct;173:75-78
pubmed: 27923594
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):584-6
pubmed: 17298881
Sci Rep. 2020 Mar 30;10(1):5677
pubmed: 32231239
Nutrients. 2016 Mar 02;8(3):135
pubmed: 26950144
J Steroid Biochem Mol Biol. 2017 Mar;167:61-66
pubmed: 27864003
J Med Chem. 2013 Sep 12;56(17):6745-60
pubmed: 23944708
Mol Cell Endocrinol. 2011 Dec 5;347(1-2):90-6
pubmed: 21693169
Biochem Biophys Res Commun. 2018 Oct 28;505(2):460-465
pubmed: 30268505
Sci Signal. 2009 Jun 16;2(75):re4
pubmed: 19531804
Nat Rev Drug Discov. 2010 Dec;9(12):941-55
pubmed: 21119732
J Steroid Biochem Mol Biol. 2018 Apr;178:333-339
pubmed: 29425808

Auteurs

Miyu Nishikawa (M)

Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.

Naruhiro Murose (N)

Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.

Hiroki Mano (H)

Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.

Kaori Yasuda (K)

Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.

Yasuhiro Isogai (Y)

Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.

Atsushi Kittaka (A)

Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1 Kaga, Itabashi, Tokyo, 173-8605, Japan.

Masashi Takano (M)

Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1 Kaga, Itabashi, Tokyo, 173-8605, Japan.

Shinichi Ikushiro (S)

Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.

Toshiyuki Sakaki (T)

Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan. tsakaki@pu-toyama.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH